- Home
- FRMI vs WST Comparison
FRMI vs WST Comparison
Compare FRMI & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRMI
- WST
- Stock Information
- Founded
- FRMI 2025
- WST 1923
- Country
- FRMI United States
- WST United States
- Employees
- FRMI N/A
- WST N/A
- Industry
- FRMI Real Estate Investment Trusts
- WST Medical/Dental Instruments
- Sector
- FRMI Real Estate
- WST Health Care
- Exchange
- FRMI Nasdaq
- WST Nasdaq
- Market Cap
- FRMI 17.4B
- WST 18.0B
- IPO Year
- FRMI 2025
- WST N/A
- Fundamental
- Price
- FRMI $28.41
- WST $263.70
- Analyst Decision
- FRMI
- WST Strong Buy
- Analyst Count
- FRMI 0
- WST 8
- Target Price
- FRMI N/A
- WST $333.71
- AVG Volume (30 Days)
- FRMI 11.6M
- WST 620.3K
- Earning Date
- FRMI 10-30-2025
- WST 10-23-2025
- Dividend Yield
- FRMI N/A
- WST 0.34%
- EPS Growth
- FRMI N/A
- WST N/A
- EPS
- FRMI N/A
- WST 6.68
- Revenue
- FRMI N/A
- WST $2,960,200,000.00
- Revenue This Year
- FRMI N/A
- WST $6.28
- Revenue Next Year
- FRMI N/A
- WST $6.11
- P/E Ratio
- FRMI N/A
- WST $39.07
- Revenue Growth
- FRMI N/A
- WST 2.90
- 52 Week Low
- FRMI $24.30
- WST $187.43
- 52 Week High
- FRMI $36.99
- WST $352.33
- Technical
- Relative Strength Index (RSI)
- FRMI N/A
- WST 54.18
- Support Level
- FRMI N/A
- WST $257.50
- Resistance Level
- FRMI N/A
- WST $265.66
- Average True Range (ATR)
- FRMI 0.00
- WST 5.80
- MACD
- FRMI 0.00
- WST -1.01
- Stochastic Oscillator
- FRMI 0.00
- WST 39.36
About FRMI Fermi Inc. Common Stock
Fermi Inc is an energy and hyperscaler development company purpose-built for the AI era. Its Project Matador, a multi-gigawatt energy and data center development campus designed to support the accelerating needs of to-be-built AI infrastructure. Through its REIT structure, Fermi offers investors exposure to AI infrastructure growth and long-term, large-scale and reliable energy development in a tax-efficient public vehicle.
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.